Soria A - Search Results

1

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.

Nozza S, Galli L, Visco F, Soria A, Canducci F, Salpietro S, Gianotti N, Bigoloni A, Torre LD, Tambussi G, Lazzarin A, Castagna A. Nozza S, et al. Among authors: soria a. AIDS. 2010 Mar 27;24(6):924-8. doi: 10.1097/QAD.0b013e3283372d76. AIDS. 2010. PMID: 20154578

2

Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.

Gianotti N, Soria A, Galli L, Castagna A, Cernuschi M, Hasson H, Lazzarin A. Gianotti N, et al. Among authors: soria a. J Med Virol. 2004 Feb;72(2):181-6. doi: 10.1002/jmv.10580. J Med Virol. 2004. PMID: 14695657

3

Once-daily saquinavir and ritonavir in treatment-experienced HIV-1-infected individuals.

Soria A, Gianotti N, Cernuschi M, Lazzarin A. Soria A, et al. New Microbiol. 2004 Jan;27(1):11-5. New Microbiol. 2004. PMID: 14964400

4

Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome.

Gianotti N, Soria A, Galli L, Giudici B, Fusetti G, Lazzarin A, Boeri E, Castagna A. Gianotti N, et al. Among authors: soria a. AIDS. 2004 Mar 26;18(5):821-3. doi: 10.1097/00002030-200403260-00018. AIDS. 2004. PMID: 15075522 No abstract available.

5

Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review.

Gianotti N, Soria A, Lazzarin A. Gianotti N, et al. Among authors: soria a. New Microbiol. 2007 Apr;30(2):79-88. New Microbiol. 2007. PMID: 17619250 Free article. Review.

6

Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced disease.

Soria A, Lazzarin A. Soria A, et al. J Acquir Immune Defic Syndr. 2007 Sep;46 Suppl 1:S19-30. doi: 10.1097/01.qai.0000286598.00313.a6. J Acquir Immune Defic Syndr. 2007. PMID: 17713422 Review.

7

Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations.

Soria A, Cavarelli M, Sala S, Alessandrini AI, Scarlatti G, Lazzarin A, Castagna A. Soria A, et al. J Med Virol. 2008 Jun;80(6):937-41. doi: 10.1002/jmv.21138. J Med Virol. 2008. PMID: 18428138

8

Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failure.

Cossarini F, Galli L, Sagnelli C, Gianotti N, Hasson H, Clementi M, Soria A, Salpietro S, Lazzarin A, Castagna A. Cossarini F, et al. Among authors: soria a. J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):179-84. doi: 10.1097/QAI.0b013e3181a56f46. J Acquir Immune Defic Syndr. 2009. PMID: 19352200

9

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N. Soria A, et al. Antivir Ther. 2009;14(3):339-47. Antivir Ther. 2009. PMID: 19474468

10

Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial.

Soria A, Danise A, Galli L, Tiberi S, Seminari E, Cossarini F, Bigoloni A, Marcotullio S, Lazzarin A, Castagna A. Soria A, et al. J Clin Virol. 2010 Mar;47(3):253-7. doi: 10.1016/j.jcv.2009.12.007. Epub 2010 Jan 6. J Clin Virol. 2010. PMID: 20056480 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters